Blood tests could spot hidden liver risk in diabetics
NCT ID NCT07098520
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study observed 40 people with type 2 diabetes to find blood markers that could identify those at risk for a serious liver condition called NASH. Researchers measured liver stiffness and calculated scores like FIB-4 and ELF to see which patients might have liver scarring. The goal is to make it easier to screen for liver problems in diabetes patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify which type 2 diabetes patients are at risk for serious liver disease, allowing for earlier monitoring and treatment.
- What could go wrong
- This was a small, observational study that only looked for markers, not a treatment. The findings may not apply to all patients and need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Kralovske Vinohrady
Prague, 100 00, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
- Could a common diabetes drug weaken your bones?
- Can a spice and a mindset shift ease diabetic nerve pain?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could a peptide injection help rebuild Insulin-Making cells?